Fresh-frozen plasma (FFP) and cryoprecipitate both contain Factors I and VIII, however thawed FFP may be stored at 1-6 degrees C for 24 hours, but thawed cryoprecipitate may only be stored at 1-6 degrees C for six hours when used for Factor VIII content. To determine whether it would be safe and effective to extend the storage period of thawed cryoprecipitate from 6 to 24 hours, Factor VIII (and fibrinogen) levels were measured in 25 units of cryoprecipitates immediately on thawing and at 6 hours and 24 hours thereafter. The Factor VIII activity level decreased to 86% of the original activity level within 6 hours, but the drop between 6 and 24 hours was relatively small. Eighty percent of the original activity was still present at 24 hours after thawing. The fibrinogen level decreased to 87% of the original level within 6 hours but remained stable between 6 and 24 hours. Additional testing showed that fibrinogen levels remained stable between 6 and 74 hours. These data suggested that the storage of thawed cryoprecipitate might be extended to 24 hours when this blood product is used for Factor VIII content and to 74 hours when it is used for fibrinogen content. Furthermore, the lack of prohibition on the use of cryoprecipitate that has been thawed for more than six hours and stored at 4 degrees C for its fibrinogen content seems reasonable.

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajcp/94.2.203DOI Listing

Publication Analysis

Top Keywords

thawed cryoprecipitate
16
factor viii
16
hours
14
hours factor
12
storage thawed
8
cryoprecipitate extended
8
stored 1-6
8
1-6 degrees
8
degrees hours
8
viii content
8

Similar Publications

Trends in blood transfusion and causes of blood wastage: a retrospective analysis in a teaching hospital.

BMC Health Serv Res

January 2025

Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, 666 Buzih Road, Taichung, 40601, Taiwan.

Background: Blood is a vital medical resource that is sourced from primarily nonremunerated donations. As Taiwan faces an aging population, increasing medical demands pose new challenges to blood resource management. Trend analysis can improve blood supply chain management and allocate blood resources more efficiently and cost-effectively.

View Article and Find Full Text PDF

Background: Intraoperative hemorrhage in cardiac surgery increases risk of morbidity and mortality. Low pre-operative and perioperative levels of fibrinogen, a key clotting factor, are associated with severity of hemorrhage and increased transfusion of blood components. The ability to supplement fibrinogen during hemorrhagic resuscitation is delayed 45-60 min because cryoprecipitated antihemophilic factor (cryo AHF) is stored frozen, due to a short post-thaw shelf life.

View Article and Find Full Text PDF

Extending the post-thaw shelf-life of cryoprecipitate when stored at refrigerated temperatures.

Vox Sang

December 2024

Research and Development, Australian Red Cross Lifeblood, Alexandria, New South Wales, Australia.

Article Synopsis
  • The study investigates the storage of thawed cryoprecipitate at 1-6°C to potentially extend its shelf-life beyond the current 6-hour limit, which leads to high wastage.
  • Over a 14-day period, various coagulation factors were monitored in mini- and full-size cryoprecipitate packs from apheresis and whole blood collections.
  • Results showed that while Factor VIII levels decreased significantly after 24 hours, most samples still met quality specifications up to 14 days post-thaw, indicating that refrigerated storage could be a viable solution.
View Article and Find Full Text PDF

Objectives: Cryoprecipitated antihemophilic factor (cryo) has been used for fibrinogen replacement in actively bleeding patients, dysfibrinogenemia, and hypofibrinogenemia. Cryo has a shelf life of 4 to 6 hours after thawing and a long turnaround time in issuing the product, posing a major limitation of its use. Recently, the US Food and Drug Administration approved Pathogen Reduced Cryoprecipitated Fibrinogen Complex (INTERCEPT Fibrinogen Complex [IFC]) for the treatment of bleeding associated with fibrinogen deficiency, which can be stored at room temperature and has a shelf life of 5 days after thawing.

View Article and Find Full Text PDF

Bleeding Reversal With Antifibrinolytics or Cryoprecipitate Following Thrombolysis for Acute Ischemic Stroke: A Case Series.

Adv Emerg Nurs J

May 2024

Author Affiliations: University of Kentucky HealthCare Pharmacy Services, Lexington, KY (Drs Platt Baum, Nestor, and Bailey); and Department of Emergency Medicine, University of Kentucky College of Medicine, Lexington, KY (D. Baum).

Patients who develop an intracerebral hemorrhage (ICH) following thrombolysis in acute ischemic stroke (AIS) have a mortality rate as high as 50%. Treatment options include blood products, such as cryoprecipitate, or antifibrinolytics, such as tranexamic acid (TXA) or ε-aminocaproic acid (EACA). Current guidelines recommend cryoprecipitate first-line despite limited data to support one agent over another.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!